Heather Brown
Psychiatric/Mental Health · Kalispell, MTNPI 1477897908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$555
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$509
- Johnson & Johnson$354
- Otsuka America Pharmaceutical, Inc.$337
- Neurocrine Biosciences, Inc.$322
- Axsome Therapeutics, Inc.$278
- plus $599 from 13 others
What the payments were for
- Food & beverage$2,75193%
- Education$2027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $555 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $509 |
| Johnson & Johnson | 9 | $354 |
| Otsuka America Pharmaceutical, Inc. | 23 | $337 |
| Neurocrine Biosciences, Inc. | 16 | $322 |
| Axsome Therapeutics, Inc. | 6 | $278 |
| Merck | 5 | $96 |
| Exact Sciences | 3 | $72 |
| Sunovion Pharmaceuticals Inc. | 9 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Harmony Biosciences LLC | 1 | $55 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $42 |
| Indivior Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Alkermes, Inc. | 2 | $33 |
| Amgen | 1 | $19 |
| Pfizer | 1 | $18 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$239
- SPRAVATO$139
- INVEGA SUSTENNA$139
How this compares
$2,953 in reported general payments places this provider in the 95th percentile of 142 psychiatric/mental health providers in Montana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 14 | $122,948 |
| AustedoDeutetrabenazine | 21 | $103,602 |
| Abilify MaintenaAripiprazole | 36 | $96,304 |
| Invega SustennaPaliperidone Palmitate | 12 | $42,283 |
| LybalviOlanzapine/Samidorphan Malate | 24 | $37,542 |
| FetzimaLevomilnacipran Hcl | 39 | $19,496 |
| VivitrolNaltrexone Microspheres | 13 | $18,868 |
| Clozapine | 198 | $9,867 |
| Fluvoxamine Maleate ErFluvoxamine Maleate | 13 | $5,557 |
| Asenapine Maleate | 17 | $4,998 |
| Aripiprazole | 59 | $4,154 |
| Lurasidone Hcl | 42 | $3,790 |
| Vilazodone Hcl | 47 | $3,708 |
| Doxepin Hcl | 43 | $1,128 |
| Haloperidol Decanoate | 18 | $1,105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $322 | $122,94814 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $57 | $103,60221 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $337 | $96,30436 claims |
| Alkermes, Inc.Lybalvi, Vivitrol | $33 | $56,41037 claims |
| Johnson & JohnsonInvega Sustenna | $354 | $42,28312 claims |
| AbbVieFetzima | $555 | $19,49639 claims |
| Lilly USA, LLCOlanzapine | $33 | $72234 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 142 psychiatric/mental health providers in Montana.
Other psychiatric/mental health in Kalispell
- Jeanette HoughtellingKalispell$583
- Sonya MilheimKalispell$538
- Allyson ArnoldKalispell$347
- Amanda KorverKalispell$259
- Tommie PerusichButte$4K
- Sherry MartinMissoula$3K
- Jill DonaldsonGreat Falls$3K
- Jennifer DurwardHavre$2K
- William BowdenGreat Falls$2K
- Susan FinnBillings$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.